http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201170780-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2009-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201170780-A1 |
| titleOfInvention | URATIC CYCLOPROPYLNUCLEOTIDES |
| abstract | The compounds of formula I are described, including any possible stereoisomers thereof, wherein R4 is hydrogen or halogen; R is a monophosphate, diphosphate or triphosphate ester; or R 1 represents a group of formula (II), R 1 represents optionally substituted phenyl; naphthyl; indolyl or N-C-C1-6alkyloxycarbonylindolyl; R 1 is hydrogen, C 1-6 alkyl, benzyl; R 1 is hydrogen, C 1-6 alkyl, benzyl; or R and R, together with the carbon atom to which they are attached, form C-Cycloalkyl; R1 is C-C1-6alkyl, C-Cycloalkyl, C-Salkenyl, benzyl or optionally substituted phenyl, or a pharmaceutically acceptable salt or solvate thereof, as well as pharmaceutical compositions and the use of compounds I as HCV inhibitors. |
| priorityDate | 2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.